FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Biomarker Qualification Case Studies

FDA publishes cases studies to help patients, health professionals, and others to learn more about the role of biomarkers and biomarker qualification ...

Human Drugs

Clarify Memory Supplement Oversight Roles: GAO

The Government Accountability Office says that consumer groups are unclear on the roles FDA and FTC play in oversight over memory and other dietary su...

Human Drugs

E14 Guidance Clarification

FDA issues an updated question-and-answer guidance to facilitate implanting the 2005 ICH E14 guidance.

Human Drugs

Millennium Raises Generic Velcade Issues

Millennium asks FDA to apply restrictions to a Fresenius 505(b)(2) application for a bortezomib product.

Federal Register

Nominations Sought for Industry Rep on Device GMP Panel

Federal Register notice: FDA seeks notice from industry organizations interested in participating in the selection of a nonvoting industry representat...

Federal Register

Comments Sought on New Drug Promotion Research on Disclosures

Federal Register notice: FDA seeks comments on proposed research entitled Disclosures in Professional and Consumer Prescription Drug Promotion.

Medical Devices

FDA Pushing Early Device Feasibility Studies

CDRHers Jeffrey Shuren and Bram Zuckerman praise Center efforts to speed innovation in heart valve devices.

Human Drugs

Phillips Recalling All Topical Products

FDA says Phillips is recalling to the retail level all lots of nine topical products produced in the last three years.

Human Drugs

Petition Asks Warnings for RLS Drugs

BioMedEcon asks for warnings on labeling of three dopamine agonists used to treat restless leg syndrome addressing risks of adverse mental disorders.

Federal Register

Workshop on Opioid Abuse Deterrent Properties/Data Needs

Federal Register notice: FDA announces a 7/10-11 public workshop entitled Data and Methods for Evaluating the Impact of Opioid Formulations with Prope...